Nathaniel S. Treister: Oral Medicine Fundamentals

Oral Medicine Fundamentals provides a focused overview of principles directly relevant to your surgical practice. You frequently encounter patients with oral mucosal disease, systemic conditions with oral manifestations, and medication-related complications. Recognizing these presentations and integrating oral medicine into your decision-making is essential for improving diagnosis, refining surgical planning, and preventing avoidable complications.

SPEAKER:

Dr. Nathaniel S. Treister DMD, DMSc is Chief of the Division of Oral Medicine and Dentistry at Brigham and Women’s Hospital and Clinical Director of Oral Medicine and Oral Oncology at the Dana-Farber/Brigham and Women's Cancer Center in Boston, Massachusetts. Dr. Treister earned his DMD from the University of Pennsylvania School of Dental Medicine and subsequently completed his Oral Medicine and Oral Biology training at the Harvard School of Dental Medicine, where he is an Associate Professor of Oral Medicine in the Department of Oral Medicine, Infection and Immunity. He is board certified in Oral Medicine and practices at Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Boston Children’s Hospital, and Dartmouth-Hitchcock Medical Center, with special interest in oral mucosal diseases, salivary gland diseases, orofacial pain disorders, and oral complications in cancer patients. He has published extensively in the field of oral medicine with an emphasis on oral complications of allogeneic hematopoietic cell transplantation and oral graft-versus-host disease, and is a past president of the American Academy of Oral Medicine. He is co-principal investigator of an NIH R01 grant entitled “Long Term Oral Health Outcomes in the Chronic GVHD Consortium” and serves as site principal investigator for an NIH U01 grant entitled “Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients”.

LEARNING OBJECTIVES:

By the end of the session, you will be able to:

1. Identify oral mucosal conditions that may influence surgical planning and management.

2. Recognize systemic diseases and medications with oral manifestations relevant to surgery.

3. Apply oral medicine principles to improve perioperative evaluation and complication prevention.

4. Integrate oral medicine considerations into multidisciplinary care for complex patients.

TARGET AUDIENCE:

• Dentists – Enhance ability to recognize oral-systemic disease connections, make timely referrals, and support surgical colleagues in comprehensive care.

• Oral & Maxillofacial Surgeons – Strengthen diagnostic accuracy and optimize outcomes in implant, trauma, and reconstructive surgery by integrating oral medicine principles.

• Head and Neck Surgeons & Reconstructive Surgeons – Improve oncologic and reconstructive planning through early identification of mucosal disease and systemic risks affecting healing.

• Plastic & Reconstructive Surgeons – Reduce postoperative complications and improve outcomes by understanding oral manifestations of systemic disease.

• Otolaryngologists (ENT Specialists) – Enhance management of mucosal lesions and therapy-related complications that directly impact head and neck surgical care.

• Residents & Fellows – Build essential knowledge of oral-systemic interactions for safer surgical training and practice.

• Researchers & Academicians – Broaden perspectives on outcomes research by integrating oral medicine into studies on surgical care and complication prevention.

ONLINE LIVE EVENT ( Free of Charge )

San Francisco: Monday, March 16, 2026 at 4:00 pm

Mexico City: Monday, March 16, 2026 at 5:00 pm

New York: Monday, March 16, 2026 at 7:00 pm

Rio de Janeiro: Monday, March 16, 2026 at 8:00 pm

London: Monday, March 16, 2026 at 11:00 pm

Berlin: Tuesday, March 17, 2026 at 12:00 midnight

Johannesburg: Tuesday, March 17, 2026 at 1:00 am

Cairo: Tuesday, March 17, 2026 at 1:00 am

Dubai: Tuesday, March 17, 2026 at 3:00 am

Delhi: Tuesday, March 17, 2026 at 4:30 am

Manila: Tuesday, March 17, 2026 at 7:00 am

Sydney: Tuesday, March 17, 2026 at 10:00 am

LANGUAGE: The event language is english. 

CME ACCREDITATION: This event may be accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 1 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. If you are a learner based in the U.S. or Canada EACCME credits are recognized by the American Medical Association (AMA) and the Royal College of Physicians and Surgeons of Canada.

DECLARATION: In accordance with criterion 13 of document UEMS 2023.07.rev “EACCME® Criteria for the Accreditation of Live Educational Events (LEEs)” and the Standard v. Commercial or Promotional Conflict of Interest, published by the American Dental Association Continuing Education Recognition Program (ADA CERP), all surgeON presenters sign a Conflict of Interest form to document all perceived or actual conflicts of interest for the last 3 years, whether due to a financial or other relationship. This document can be viewed at the beginning of the event or on request by emailing info@surgeon-events.org No fee, honorarium or arrangement for re-imbursement of expenses in relation to the this event has been provided to the speaker.